Skip to main content
Avisa Diagnostics Inc. logo

Avisa Diagnostics Inc. — Investor Relations & Filings

Ticker · FOGCF ISIN · CA05380J1075 LEI · 254900OX0MBH7RKUG944 CSE Manufacturing
Filings indexed 44 across all filing types
Latest filing 2021-05-06 Regulatory Filings
Country CA Canada
Listing CSE FOGCF

About Avisa Diagnostics Inc.

https://www.avisadx.com

Avisa Diagnostics Inc. is a clinical-stage medical device company specializing in the rapid detection of infectious pulmonary diseases. The core product is the Avisa BreathTest, a novel drug/device biomarker technology platform. This point-of-care test utilizes pulmonary assays to facilitate the early identification and treatment of lung infections. The technology is currently in late-stage clinical development, with trials focused on critical indications such as cystic fibrosis, tuberculosis, community-acquired pneumonia, ventilator-associated pneumonia, and Post-COVID-19 bronchiectasis.

Recent filings

Filing Released Lang Actions
Notice.pdf
Regulatory Filings
2021-05-06 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings
2021-05-01 English
Audited annual financial statements – English.pdf
Regulatory Filings
2021-05-01 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings
2021-05-01 English
Annual MD&A - English.pdf
Regulatory Filings
2021-05-01 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2021-05-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.